ZYME Stock Analysis: Buy, Sell, or Hold?
ZYME - Zymeworks Inc.
$24.35
0.24 (1.00%)
▲
5d:
-1.77%
30d:
-9.07%
90d:
-3.49%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ZYME Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ZYME shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ZYME shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.68
Based on -29.3% avg growth
INTRINSIC VALUE TODAY
$1.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZYME is currently trading at $24.35, which is considered slightly low relative to its 30-day fair value range of $24.26 to $27.27. From a valuation perspective, the stock is trading at a discount (Forward PE: 47.2) compared to its historical average (63.3). Remarkably, the market is currently pricing in an annual earnings decline of 9.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ZYME is in a uptrend. The price is currently testing key support at $23.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ZYME has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $40.15 (+64.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ZYME is in a uptrend. The price is currently testing key support at $23.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ZYME has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $40.15 (+64.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$24.26 -
$27.27
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding ZYME? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.9% below Wall St target ($40.15)
Trading Range Analysis
30-Day Trading Range
$24.26 -
$27.27
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$23.93
Resistance Level
$26.19
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
47.22
Wall Street Target
$40.15
(+64.9%)
Revenue Growth (YoY)
-91.1%
Profit Margin
-126.3%
Valuation Discount vs History
-9.3% cheaper
PE vs Historical
47.2 vs 63.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.3%
(market-implied from PE analysis)
1-Year Target
$22.09
(-9%)
2-Year Target
$20.03
(-18%)
3-Year Target
$18.17
(-25%)
3-Yr Target (if PE normalizes)
(PE: 47→63)
$24.36
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 47.2, Growth: -62.5%)
$17.75
(+-27%)
Base:
(SPY PE: 21.9, Growth: -62.5%)
$8.24
(-66%)
Bear:
(PE: 18.6, Growth: -62.5%)
$7.00
(-71%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 47.2 to 63.3
Stabilization Target:
$32.64
(+34.1%)
PE Expansion Potential:
+34.1%
Share & Embed Analysis
Last updated: June 03, 2026 6:57 PM ET
Data refreshes hourly during market hours. Next update: 7:57 PM
Data refreshes hourly during market hours. Next update: 7:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZYME showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeffrey T L Smith
SELL
9310 shares
2026-01-12
Kenneth Galbraith
SELL
30424 shares
2026-01-12
Mark Hollywood
SELL
6120 shares
2026-01-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$446 | 60 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 48 HOLD |
Advanced ZYME Option Strategies
Professional options setups generated by AI based on today's ZYME price and gamma walls.
